Cart
sales@molnova.com
(3aR,9aR)-Fluparoxan
CAS No. 105182-47-6
(3aR,9aR)-Fluparoxan( —— )
Catalog No. M36955 CAS No. 105182-47-6
(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 409 | In Stock |
|
| 10MG | 604 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1265 | In Stock |
|
| 100MG | 1702 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3422 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(3aR,9aR)-Fluparoxan
-
NoteResearch use only, not for human use.
-
Brief Description(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.
-
Description(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdrenergic Receptor
-
RecptorAdrenergic Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105182-47-6
-
Formula Weight195.19
-
Molecular FormulaC10H10FNO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC1=C2C(O[C@]3([C@](O2)(CNC3)[H])[H])=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-00610355
PF-00610355 (PF 610355) is a potent, selective, and long-acting β2-adrenoreceptor agonist with EC50 of 0.26 nM.
-
Atipamezole
Antipamezole (MPV-1248) is a potent, specific α2-adrenoceptor antagonist with Ki of 1.6 nM.
-
Fluparoxan hydrochlo...
Fluparoxan hydrochloride is a highly selective and potent α2-adrenoceptor antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.
